SCHEMBL9080957

SCHEMBL9080957

CC(=O)c1c(C)nc2c(NC(=O)c3c(Cl)cccc3Cl)cccn12

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
MEN1 O00255 3/20 0.46
CRHBP P24387 1/20 0.46
HTT P42858 1/20 0.46
CRHR2 Q13324 1/20 0.46
EPHB3 P54753 2/20 0.44
RAB9A P51151 2/20 0.41
HPGD P15428 1/20 0.40
TYK2 P29597 2/20 0.40
ALDH1A1 P00352 1/20 0.40
JAK2 O60674 1/20 0.40
CYP3A4 P08684 1/20 0.40
JAK1 P23458 1/20 0.40
MAPT P10636 1/20 0.40
PTGES O14684 1/20 0.40
NPC1 O15118 1/20 0.40
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9230500 0.91 EPHB3 (0.46) KMT2ASMN1; SMN2MEN1CRHBPHTT
SCHEMBL9081354 0.86 KMT2A (0.48) KMT2ASMN1; SMN2MEN1CRHBPHTT
SCHEMBL9080404 0.86 KMT2A (0.48) KMT2ASMN1; SMN2MEN1CRHBPHTT
Hydrochloric Acid SCHEMBL9081789 0.85 KMT2A (0.47) KMT2ASMN1; SMN2MEN1CRHBPHTT
SCHEMBL9278391 0.84 KMT2A (0.46) KMT2ASMN1; SMN2MEN1CRHBPHTT
SCHEMBL9082171 0.84 KMT2A (0.46) KMT2ASMN1; SMN2MEN1CRHBPHTT
SCHEMBL9080393 0.84 KMT2A (0.44) KMT2ASMN1; SMN2MEN1CRHBPHTT
SCHEMBL9081462 0.83 KMT2A (0.48) KMT2ASMN1; SMN2MEN1CRHBPHTT
Hydrochloric Acid SCHEMBL9080790 0.83 KMT2A (0.43) KMT2ASMN1; SMN2MEN1CRHBPHTT
SCHEMBL9081440 0.82 KMT2A (0.45) KMT2ASMN1; SMN2MEN1CRHBPHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996034866-A1 IMIDAZO 1,2-A PYRIDINE AND IMIDAZO 1,2-A PYRIDEZINE DERIVATIVES AND THEIR USE AS BONE RESORPTION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-11-07 WO disclosed